Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
inclisiran
7
×
life sciences
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
boston top stories
national top stories
biotech
clinical trials
cholesterol
new york
pcsk9
praluent
repatha
san francisco blog main
san francisco top stories
alirocumab
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
evolocumab
indiana blog main
indiana top stories
medicines co.
national
pcsk9 inhibitors
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
What
cholesterol
drug
lowering
medco
medicines
new
fda
roundup
twice
wave
abbvie’s
according
aces
acquire
agreed
akcea
alnylam
announced
barbecuing
based
big
billion
bio
biotech
bringing
brings
camping
cardiologist
cases
cash
center
centers
ceo
check
cigarettes
clears
closer
company
compound
conference
Language
unset
Current search:
inclisiran
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms